Clinical trial
A Study to Optimize Growth Hormone Dosing in Children With Chronic Kidney…
NCT00212758 · Oregon Health and Science University, Other · Completed
Key facts
| NCT number | NCT00212758 |
|---|---|
| Title | A Study to Optimize Growth Hormone Dosing in Children With Chronic Kidney Disease by Measuring IGF-1 Levels in Blood |
| Official title | IGF-1 Generation Test in Children With Chronic Kidney Disease |
| Lead sponsor | Oregon Health and Science University, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Kidney Failure, Chronic, Growth Hormone Deficiency |
| Intervention type | Drug |
| Interventions | Nutropin AQ |
| Enrollment | 17 |
| Start date | Jan 1, 2005 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2010 |
| First posted | Sep 21, 2005 |
| Last update posted | Oct 26, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: